Literature DB >> 3137168

Modulation of infection by gamma interferon treatment following trauma.

M J Hershman1, H C Polk, J D Pietsch, R E Shields, S R Wellhausen, G Sonnenfeld.   

Abstract

Gamma interferon (IFN-gamma) has been shown to be able to modulate several microbiol infections, perhaps as a result of the immunoregulatory properties of this interferon. The present study was designed to determine the efficacy of IFN-gamma treatment in a mouse model of infection that simulates clinical conditions occurring following abdominal trauma. In this model, mice were first infected intraperitoneally with Escherichia coli and then underwent immediate surgical laparotomy. Finally the mice were secondarily infected intramuscularly with Klebsiella pneumoniae. Groups of CBA/J mice received either IFN-gamma or RPMI 1640 medium (controls) subcutaneously. IFN-gamma was administered daily at a dose of 7,500 U, commencing 1 h postlaparotomy and continuing until the second bacterial challenge. Mice treated with IFN-gamma survived significantly longer than controls. The Ia antigen expression of peripheral blood monocytes was severely reduced in animals for 3 days after laparotomy and for 5 days after laparotomy and infection. This drop in Ia antigen expression was prevented in animals treated with IFN-gamma. These data indicate that IFN-gamma had a beneficial effect in a model simulating bacterial infection after trauma and that maintenance of Ia antigen expression in interferon-treated mice may have contributed to the observed therapeutic effect.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3137168      PMCID: PMC259581          DOI: 10.1128/iai.56.9.2412-2416.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  A systematic study of host defense processes in badly injured patients.

Authors:  H C Polk; C D George; S R Wellhausen; K Cost; P R Davidson; M P Regan; A P Borzotta
Journal:  Ann Surg       Date:  1986-09       Impact factor: 12.969

2.  Trimethoprim metabolites in rat, dog and man: qualitative and quantitative studies.

Authors:  D E Schwartz; W Vetter; G Englert
Journal:  Arzneimittelforschung       Date:  1970-12

3.  Characterization of the antiviral activity produced during Trypanosoma cruzi infection and protective effects of exogenous interferon against experimental Chagas' disease.

Authors:  F Kierszenbaum; G Sonnenfeld
Journal:  J Parasitol       Date:  1982-04       Impact factor: 1.276

4.  [Interferon inhibition of the development of a staphylococcal infection].

Authors:  V S Zueva; V P Kuznetsov; N Ia Spivak; L M Avakian
Journal:  Antibiot Med Biotekhnol       Date:  1985-11

5.  Mouse fibroblast interferon modifies Salmonella typhimurium infection in infant mice.

Authors:  G Bukholm; B P Berdal; C Haug; M Degré
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

6.  Causes of death after blunt trauma.

Authors:  R J Goris; J Draaisma
Journal:  J Trauma       Date:  1982-02

7.  [Effect of interferon type I on the in vivo persistence of Salmonella typhimurium].

Authors:  I V Fil'chakov; N Ia Spivak; A M Zaritskiĭ; V S Zueva; V P Kuznetsov
Journal:  Zh Mikrobiol Epidemiol Immunobiol       Date:  1986-02

8.  Effects of passive transfer and induction of gamma (type II immune) interferon preparations on the metabolism of diphenylhydantoin by murine cytochrome P-450.

Authors:  C L Harned; D E Nerland; G Sonnenfeld
Journal:  J Interferon Res       Date:  1982

9.  Effect of treatment of mice with sera containing gamma interferon on the course of infection with Salmonella typhimurium strain LT-2.

Authors:  Z Izadkhah; A D Mandel; G Sonnenfeld
Journal:  J Interferon Res       Date:  1980

10.  Alteration of monocyte function following major injury.

Authors:  E Faist; A Mewes; T Strasser; A Walz; S Alkan; C Baker; W Ertel; G Heberer
Journal:  Arch Surg       Date:  1988-03
View more
  6 in total

1.  Interferon gamma in trauma-related infections.

Authors:  D J Dries
Journal:  Intensive Care Med       Date:  1996-10       Impact factor: 17.440

2.  Rationale, design and performance of a clinical trial to investigate interferon-gamma (Imukin) in the prophylactic treatment of severe burns-related infections.

Authors:  J D Ioannovich; R D Hinzmann; G Deichsel; G G Steinmann
Journal:  Intensive Care Med       Date:  1996-10       Impact factor: 17.440

3.  Physiological and morphological changes in bovine mammary glands following intramammary infusion of recombinant interferon-gamma.

Authors:  L M Sordillo; M Snider; L A Babiuk
Journal:  Can J Vet Res       Date:  1992-01       Impact factor: 1.310

4.  Early decrease in surface expression of HLA-DQ predicts the development of infection in trauma patients.

Authors:  J V Taylor; L E Gordon; H C Polk
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

5.  Respiratory burst capacity of activated macrophages is resistant to depression by erythrocyte phagocytosis.

Authors:  M G Schwacha; D J Loegering
Journal:  Inflammation       Date:  1992-08       Impact factor: 4.092

6.  Inhibition of macrophage-activating cytokines is beneficial in the acute septic response.

Authors:  H P Redmond; K D Chavin; J S Bromberg; J M Daly
Journal:  Ann Surg       Date:  1991-10       Impact factor: 12.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.